Interestingly, several studies have demonstrated that in subsets of cancer cells, and specifically breast cancer cells, EGFR function changes from proliferative in primary tumors to growth-inhibitory and apoptotic in metastatic tumors35–39. Here, EGFR is linked to breast cancer.